Invention Grant
- Patent Title: Hydroxyphenyl sulfonamides as antiapoptotic bcl inhibitors
- Patent Title (中): 羟基苯基磺酰胺作为抗凋亡性bcl抑制剂
-
Application No.: US13055056Application Date: 2009-06-08
-
Publication No.: US08501992B2Publication Date: 2013-08-06
- Inventor: Kyoung S. Kim , Robert M. Borzilleri , Zhen-Wei Cai , Kap-Sun Yeung
- Applicant: Kyoung S. Kim , Robert M. Borzilleri , Zhen-Wei Cai , Kap-Sun Yeung
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent Mary K. VanAtten; Gary D. Greenblatt
- International Application: PCT/US2009/046579 WO 20090608
- International Announcement: WO2009/152082 WO 20091217
- Main IPC: C07C311/00
- IPC: C07C311/00
Abstract:
The present invention provides compound of Formula (I): or a stereoisomer, tautomer, salt or solvate thereof, wherein the variables are defined herein. The compounds of formula (I) are inhibitors of Bcl-2 family antiapoptotic proteins, compositions containing the compounds and methods of treating diseases using the compounds.
Public/Granted literature
- US20110294793A1 HYDROXYPHENYL SULFONAMIDES AS ANTIAPOPTOTIC BCL INHIBITORS Public/Granted day:2011-12-01
Information query
